2020 Q4 Form 10-Q Financial Statement

#000116692820000125 Filed on October 29, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $25.75M $24.61M $25.61M
YoY Change 2.67% -3.91% 16.84%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $370.0K $380.0K $360.0K
YoY Change 0.0% 5.56% 2.86%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $3.256M $3.478M $8.496M
YoY Change -57.66% -59.06% 36.31%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $10.68M $10.28M $9.438M
YoY Change 11.79% 8.88% -2.1%
Income Tax $2.125M $2.176M $1.912M
% Of Pretax Income 19.9% 21.18% 20.26%
Net Earnings $8.554M $8.100M $7.526M
YoY Change 12.45% 7.63% 5.51%
Net Earnings / Revenue 33.22% 32.91% 29.38%
Basic Earnings Per Share $0.52 $0.49 $0.46
Diluted Earnings Per Share $0.52 $0.49 $0.46
COMMON SHARES
Basic Shares Outstanding 16.47M shares 16.47M shares 16.38M shares
Diluted Shares Outstanding 16.52M shares 16.47M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $396.4M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $29.08M $28.10M $30.06M
YoY Change -2.03% -6.51% 38.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.30M $10.80M $6.100M
YoY Change 109.26% 77.05% -11.59%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $3.186B $2.776B $2.457B
YoY Change 28.79% 12.97% 13.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $38.70M $43.80M $27.40M
YoY Change 78.34% 59.85% 356.67%
Deferred Revenue
YoY Change
Short-Term Debt $5.400M $2.400M $3.500M
YoY Change 100.0% -31.43% -86.64%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $38.70M $43.80M $27.40M
YoY Change 78.34% 59.85% 356.67%
LONG-TERM LIABILITIES
Long-Term Debt $42.00M $42.70M $43.40M
YoY Change -3.23% -1.61% 14.21%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $42.00M $42.70M $43.40M
YoY Change -3.23% -1.61% 14.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $38.70M $43.80M $27.40M
Total Long-Term Liabilities $42.00M $42.70M $43.40M
Total Liabilities $2.962B $2.561B $2.253B
YoY Change 30.96% 13.65% 13.39%
SHAREHOLDERS EQUITY
Retained Earnings $203.7M $198.6M $180.7M
YoY Change 10.22% 9.95% 9.0%
Common Stock $3.000M $3.000M $3.000M
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $223.7M $215.3M $204.1M
YoY Change
Total Liabilities & Shareholders Equity $3.186B $2.776B $2.457B
YoY Change 28.79% 12.97% 13.15%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $8.554M $8.100M $7.526M
YoY Change 12.45% 7.63% 5.51%
Depreciation, Depletion And Amortization $370.0K $380.0K $360.0K
YoY Change 0.0% 5.56% 2.86%
Cash From Operating Activities $11.23M $7.530M $10.69M
YoY Change 16.13% -29.56% 7.33%
INVESTING ACTIVITIES
Capital Expenditures -$1.710M -$180.0K -$320.0K
YoY Change 402.94% -43.75% 1500.0%
Acquisitions
YoY Change
Other Investing Activities -$82.04M -$86.73M -$55.47M
YoY Change -14.47% 56.35% 264.45%
Cash From Investing Activities -$83.75M -$86.92M -$55.77M
YoY Change -13.01% 55.85% 265.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 403.1M 28.56M 81.80M
YoY Change 3699.43% -65.09% -351.38%
NET CHANGE
Cash From Operating Activities 11.23M 7.530M 10.69M
Cash From Investing Activities -83.75M -86.92M -55.77M
Cash From Financing Activities 403.1M 28.56M 81.80M
Net Change In Cash 330.6M -50.83M 36.72M
YoY Change -535.06% -238.43% -197.09%
FREE CASH FLOW
Cash From Operating Activities $11.23M $7.530M $10.69M
Capital Expenditures -$1.710M -$180.0K -$320.0K
Free Cash Flow $12.94M $7.710M $11.01M
YoY Change 29.27% -29.97% 10.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001166928
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-49677
dei Entity Registrant Name
EntityRegistrantName
WEST BANCORPORATION, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
IA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
42-1230603
dei Entity Address Address Line1
EntityAddressAddressLine1
1601 22nd Street
dei Entity Address City Or Town
EntityAddressCityOrTown
West Des Moines
dei Entity Address State Or Province
EntityAddressStateOrProvince
IA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
50266
dei City Area Code
CityAreaCode
(515)
dei Local Phone Number
LocalPhoneNumber
222-2300
dei Security12b Title
Security12bTitle
Common stock, no par value
dei Trading Symbol
TradingSymbol
WTBA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16469272 shares
CY2020Q3 us-gaap Cash And Due From Banks
CashAndDueFromBanks
49445000 USD
CY2019Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
37808000 USD
CY2020Q3 us-gaap Federal Funds Sold
FederalFundsSold
16398000 USD
CY2019Q4 us-gaap Federal Funds Sold
FederalFundsSold
15482000 USD
CY2020Q3 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
65843000 USD
CY2019Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
53290000 USD
CY2020Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
374387000 USD
CY2019Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
398578000 USD
CY2020Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
11905000 USD
CY2019Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
12491000 USD
CY2020Q3 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
2247425000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1941663000 USD
CY2020Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
25403000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
17235000 USD
CY2020Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2222022000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1924428000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28099000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29680000 USD
CY2020Q3 us-gaap Interest Receivable
InterestReceivable
11071000 USD
CY2019Q4 us-gaap Interest Receivable
InterestReceivable
7134000 USD
CY2020Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
42520000 USD
CY2019Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
34893000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10809000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5361000 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
9227000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
7836000 USD
CY2020Q3 us-gaap Assets
Assets
2775883000 USD
CY2019Q4 us-gaap Assets
Assets
2473691000 USD
CY2020Q3 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
619346000 USD
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
380079000 USD
CY2020Q3 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
363430000 USD
CY2019Q4 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
346307000 USD
CY2020Q3 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
1130582000 USD
CY2019Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
996836000 USD
CY2020Q3 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
54241000 USD
CY2019Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
81871000 USD
CY2020Q3 wtba Timedepositslessthan250000
Timedepositslessthan250000
129181000 USD
CY2019Q4 wtba Timedepositslessthan250000
Timedepositslessthan250000
209663000 USD
CY2020Q3 us-gaap Deposits
Deposits
2296780000 USD
CY2019Q4 us-gaap Deposits
Deposits
2014756000 USD
CY2020Q3 us-gaap Federal Funds Purchased
FederalFundsPurchased
2350000 USD
CY2019Q4 us-gaap Federal Funds Purchased
FederalFundsPurchased
2660000 USD
CY2020Q3 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
20448000 USD
CY2019Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
20438000 USD
CY2020Q3 wtba Federal Home Loan Bank Advances Net Of Discount
FederalHomeLoanBankAdvancesNetOfDiscount
175000000 USD
CY2019Q4 wtba Federal Home Loan Bank Advances Net Of Discount
FederalHomeLoanBankAdvancesNetOfDiscount
179365000 USD
CY2020Q3 us-gaap Other Long Term Debt
OtherLongTermDebt
22213000 USD
CY2019Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
22925000 USD
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
43772000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
21727000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
2560563000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
2261871000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16469272 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16469272 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16379752 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16379752 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
3000000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
3000000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28227000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27260000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
198622000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
184821000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14529000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3261000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
215320000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
211820000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2775883000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2473691000 USD
CY2020Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
22489000 USD
CY2019Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
22203000 USD
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
67132000 USD
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
63699000 USD
CY2020Q3 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
1728000 USD
CY2019Q3 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
2445000 USD
us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
6105000 USD
us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
7405000 USD
CY2020Q3 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
378000 USD
CY2019Q3 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
353000 USD
us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
994000 USD
us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
1675000 USD
CY2020Q3 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
15000 USD
CY2019Q3 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
611000 USD
us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
256000 USD
us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
819000 USD
CY2020Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
24610000 USD
CY2019Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
25612000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
74487000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
73598000 USD
CY2020Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1946000 USD
CY2019Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
6771000 USD
us-gaap Interest Expense Deposits
InterestExpenseDeposits
9343000 USD
us-gaap Interest Expense Deposits
InterestExpenseDeposits
19405000 USD
CY2020Q3 us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
2000 USD
CY2019Q3 us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
17000 USD
CY2020Q3 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
254000 USD
us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
21000 USD
us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
219000 USD
CY2019Q3 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
258000 USD
us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
762000 USD
us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
766000 USD
CY2020Q3 wtba Interest Expense Fhlb Advances
InterestExpenseFHLBAdvances
1189000 USD
CY2019Q3 wtba Interest Expense Fhlb Advances
InterestExpenseFHLBAdvances
1300000 USD
wtba Interest Expense Fhlb Advances
InterestExpenseFHLBAdvances
3702000 USD
wtba Interest Expense Fhlb Advances
InterestExpenseFHLBAdvances
3666000 USD
CY2020Q3 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
87000 USD
CY2019Q3 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
150000 USD
us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
316000 USD
us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
499000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
3478000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
8496000 USD
us-gaap Interest Expense
InterestExpense
14144000 USD
us-gaap Interest Expense
InterestExpense
24555000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
21132000 USD
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
17116000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
60343000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
49043000 USD
CY2020Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4000000 USD
CY2019Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
300000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
8000000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
300000 USD
CY2020Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
17132000 USD
CY2019Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
16816000 USD
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
52343000 USD
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
48743000 USD
CY2020Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
133000 USD
CY2019Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
168000 USD
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
427000 USD
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
482000 USD
CY2020Q3 wtba Loanswapfees
Loanswapfees
983000 USD
CY2019Q3 wtba Loanswapfees
Loanswapfees
0 USD
wtba Loanswapfees
Loanswapfees
1572000 USD
wtba Loanswapfees
Loanswapfees
0 USD
CY2020Q3 us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
156000 USD
CY2019Q3 us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
1000 USD
us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
81000 USD
us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
-64000 USD
CY2020Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
337000 USD
CY2019Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
361000 USD
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
993000 USD
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
1246000 USD
CY2020Q3 us-gaap Noninterest Income
NoninterestIncome
3203000 USD
CY2019Q3 us-gaap Noninterest Income
NoninterestIncome
2158000 USD
us-gaap Noninterest Income
NoninterestIncome
7498000 USD
us-gaap Noninterest Income
NoninterestIncome
6276000 USD
CY2020Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5412000 USD
CY2019Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5440000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
16014000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
16324000 USD
CY2020Q3 us-gaap Occupancy Net
OccupancyNet
1383000 USD
CY2019Q3 us-gaap Occupancy Net
OccupancyNet
1379000 USD
us-gaap Occupancy Net
OccupancyNet
4092000 USD
us-gaap Occupancy Net
OccupancyNet
3956000 USD
CY2020Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
614000 USD
CY2019Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
695000 USD
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1882000 USD
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2091000 USD
CY2020Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
351000 USD
CY2019Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
0 USD
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
880000 USD
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
404000 USD
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
230000 USD
CY2019Q3 us-gaap Professional Fees
ProfessionalFees
204000 USD
us-gaap Professional Fees
ProfessionalFees
669000 USD
us-gaap Professional Fees
ProfessionalFees
647000 USD
CY2020Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
236000 USD
CY2019Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
233000 USD
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
664000 USD
us-gaap Other Noninterest Expense
OtherNoninterestExpense
4666000 USD
CY2020Q3 us-gaap Noninterest Expense
NoninterestExpense
10059000 USD
CY2019Q3 us-gaap Noninterest Expense
NoninterestExpense
9536000 USD
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
742000 USD
CY2020Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1833000 USD
CY2019Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1585000 USD
us-gaap Other Noninterest Expense
OtherNoninterestExpense
4938000 USD
us-gaap Noninterest Expense
NoninterestExpense
29139000 USD
us-gaap Noninterest Expense
NoninterestExpense
28830000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10276000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9438000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30702000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
26189000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2176000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1912000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6544000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5106000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8100000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
7526000 USD
us-gaap Net Income Loss
NetIncomeLoss
24158000 USD
us-gaap Net Income Loss
NetIncomeLoss
21083000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.29
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.28
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8100000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
7526000 USD
us-gaap Net Income Loss
NetIncomeLoss
24158000 USD
us-gaap Net Income Loss
NetIncomeLoss
21083000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
357000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1706000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
6171000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
13673000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
156000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
1000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
81000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-64000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
50000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
426000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
1522000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
3434000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
151000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1279000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4568000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
10303000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
256000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-5187000 USD
CY2020 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0 loans
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-23912000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-12357000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-1405000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
100000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-2768000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
351000 USD
CY2020Q3 wtba Othercomprehensiveincomelossreclassificationadjustmentfrom Aoc Iforamortizationofderivativeterminationcosts
OthercomprehensiveincomelossreclassificationadjustmentfromAOCIforamortizationofderivativeterminationcosts
0 USD
CY2019Q3 wtba Othercomprehensiveincomelossreclassificationadjustmentfrom Aoc Iforamortizationofderivativeterminationcosts
OthercomprehensiveincomelossreclassificationadjustmentfromAOCIforamortizationofderivativeterminationcosts
-24000 USD
wtba Othercomprehensiveincomelossreclassificationadjustmentfrom Aoc Iforamortizationofderivativeterminationcosts
OthercomprehensiveincomelossreclassificationadjustmentfromAOCIforamortizationofderivativeterminationcosts
-31000 USD
wtba Othercomprehensiveincomelossreclassificationadjustmentfrom Aoc Iforamortizationofderivativeterminationcosts
OthercomprehensiveincomelossreclassificationadjustmentfromAOCIforamortizationofderivativeterminationcosts
-71000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
415000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
-1315000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
-5277000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
-3156000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1246000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-3948000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-15836000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9497000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4857000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-9481000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1397000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2669000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11268000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
822000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12890000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21905000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
208687000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8100000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1397000 USD
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.21
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3459000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
595000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
215320000 USD
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0 loans
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
201935000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
7526000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2669000 USD
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.21
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3439000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
784000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
204137000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
211820000 USD
us-gaap Net Income Loss
NetIncomeLoss
24158000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11268000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.63
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10357000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
1716000 USD
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
749000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
215320000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
191023000 USD
CY2019Q4 wtba Troubled Debt Restructured Loans Includedin Nonaccrual
TroubledDebtRestructuredLoansIncludedinNonaccrual
4000 USD
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0 loans
CY2020Q3 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0 loans
us-gaap Net Income Loss
NetIncomeLoss
21083000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
822000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10138000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
2208000 USD
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
861000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
204137000 USD
us-gaap Net Income Loss
NetIncomeLoss
24158000 USD
us-gaap Net Income Loss
NetIncomeLoss
21083000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
8000000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
300000 USD
wtba Netamortizationandaccretion
Netamortizationandaccretion
1628000 USD
wtba Netamortizationandaccretion
Netamortizationandaccretion
2895000 USD
us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
81000 USD
us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
-64000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1716000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2208000 USD
CY2020Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2255196000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1943903000 USD
CY2020Q3 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
-7771000 USD
CY2019Q3 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0 loans
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
427000 USD
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
482000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
307000 USD
us-gaap Depreciation
Depreciation
1131000 USD
us-gaap Depreciation
Depreciation
1060000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1693000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
155000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
3937000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
364000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
231000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
932000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
798000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1623000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31062000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27303000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
133212000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
134548000 USD
us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
9334000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
156437000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
54736000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
33477000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
158540000 USD
us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
23378000 USD
us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
9920000 USD
us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
23730000 USD
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
305594000 USD
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
114847000 USD
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
7200000 USD
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
0 USD
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
0 USD
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
604000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
605000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
708000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-283405000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-59233000 USD
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
282024000 USD
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
130278000 USD
us-gaap Increase Decrease In Federal Funds Purchased
IncreaseDecreaseInFederalFundsPurchased
310000 USD
us-gaap Increase Decrease In Federal Funds Purchased
IncreaseDecreaseInFederalFundsPurchased
16450000 USD
wtba Proceeds From Repayments Of Federal Home Loan Bank Borrowings
ProceedsFromRepaymentsOfFederalHomeLoanBankBorrowings
5000000 USD
wtba Proceeds From Repayments Of Federal Home Loan Bank Borrowings
ProceedsFromRepaymentsOfFederalHomeLoanBankBorrowings
-15000000 USD
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
712000 USD
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
4086000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10357000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10138000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
749000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
861000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
264896000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
113743000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12553000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
81813000 USD
CY2019Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
53290000 USD
CY2018Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
47474000 USD
CY2020Q3 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
65843000 USD
CY2019Q3 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
129287000 USD
us-gaap Interest Paid Net
InterestPaidNet
15034000 USD
us-gaap Interest Paid Net
InterestPaidNet
23726000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
7590000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
3280000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10435000 USD
us-gaap Use Of Estimates
UseOfEstimates
In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses for the reporting period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term are the fair value of financial instruments and the allowance for loan losses
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8100000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
7526000 USD
us-gaap Net Income Loss
NetIncomeLoss
24158000 USD
us-gaap Net Income Loss
NetIncomeLoss
21083000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16470000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16380000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16439000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16352000 shares
CY2019Q4 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
-2240000 USD
CY2020Q3 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
2247425000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1941663000 USD
CY2020Q3 wtba Covid19 Loan Modification
COVID19LoanModification
434361000 USD
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2020Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
54000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
86000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
59000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
79000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16524000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16466000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16498000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16431000 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.29
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.28
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
243000 shares
CY2020Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
366889000 USD
CY2020Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
9335000 USD
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
160000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
251000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
183000 shares
CY2020Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1837000 USD
CY2020Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
374387000 USD
CY2019Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
397169000 USD
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3699000 USD
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2290000 USD
CY2019Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
398578000 USD
CY2020Q3 us-gaap Pledged Financial Instruments Not Separately Reported Securities Pledged
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged
165424000 USD
CY2019Q4 us-gaap Pledged Financial Instruments Not Separately Reported Securities Pledged
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged
148257000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1125000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1130000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
20205000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
19829000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis
41999000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue
41127000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenAmortizedCostBasis
95991000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenFairValue
97968000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
159320000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
160054000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
207569000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
214333000 USD
CY2020Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
366889000 USD
CY2020Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
374387000 USD
CY2020Q3 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
54631000 USD
CY2019Q3 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
11095000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
133212000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
156437000 USD
CY2020Q3 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
318000 USD
CY2019Q3 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
37000 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
1773000 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
868000 USD
CY2020Q3 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
162000 USD
CY2019Q3 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
36000 USD
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
1692000 USD
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
932000 USD
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1423000 USD
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
14581000 USD
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
414000 USD
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
77316000 USD
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
91897000 USD
CY2020Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
1837000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
150616000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1142000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
56826000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1148000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
207442000 USD
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
2290000 USD
CY2020Q3 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
0 USD
CY2020Q3 wtba Troubled Debt Restructured Loans Includedin Nonaccrual
TroubledDebtRestructuredLoansIncludedinNonaccrual
0 USD
CY2019Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
4000 USD
CY2019 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0 loans
CY2020Q3 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
16298000 USD
CY2020Q3 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
16298000 USD
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
538000 USD
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
538000 USD
CY2020Q3 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
1474000 USD
CY2020Q3 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
1474000 USD
CY2019Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
0 USD
CY2019Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
0 USD
CY2020Q3 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
17772000 USD
CY2020Q3 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
17772000 USD
CY2020Q3 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
210000 USD
CY2019Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
538000 USD
CY2019Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
538000 USD
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
0 USD
CY2020Q3 wtba Number Of Borrowers Impaired Loans
NumberOfBorrowersImpairedLoans
3 Borrowers
CY2019Q4 wtba Number Of Borrowers Impaired Loans
NumberOfBorrowersImpairedLoans
6 Borrowers
CY2020Q3 wtba Loans Impaired Commitmentto Lend
LoansImpairedCommitmenttoLend
0 USD
CY2019Q4 wtba Loans Impaired Commitmentto Lend
LoansImpairedCommitmenttoLend
0 USD
CY2020Q3 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
4365000 USD
CY2020Q3 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
5000 USD
CY2019Q3 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
902000 USD
CY2019Q3 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
61000 USD
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
2044000 USD
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
20000 USD
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
1377000 USD
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
69000 USD
CY2020Q3 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
369000 USD
CY2020Q3 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
0 USD
CY2019Q3 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
45000 USD
CY2019Q3 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
6000 USD
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
148000 USD
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
0 USD
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
85000 USD
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
6000 USD
CY2020Q3 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
4734000 USD
CY2020Q3 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
5000 USD
CY2019Q3 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
947000 USD
CY2019Q3 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
67000 USD
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
2192000 USD
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
20000 USD
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
1462000 USD
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
75000 USD
CY2020Q3 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
1792000 USD
CY2020Q3 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
2235632000 USD
CY2020Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
17772000 USD
CY2020Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2255196000 USD
CY2019Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
228000 USD
CY2019Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
1943137000 USD
CY2019Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
538000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1943903000 USD
CY2020Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2255196000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1943903000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
21363000 USD
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
0 USD
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
40000 USD
CY2020Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4000000 USD
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
25403000 USD
CY2019Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16737000 USD
CY2019Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
199000 USD
CY2019Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
204000 USD
CY2019Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
300000 USD
CY2019Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
17042000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
17235000 USD
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1000 USD
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
169000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
8000000 USD
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
25403000 USD
CY2018Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16689000 USD
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
254000 USD
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
307000 USD
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
300000 USD
CY2019Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
17042000 USD
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
210000 USD
CY2020Q3 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
25193000 USD
CY2020Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
25403000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
17235000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
17235000 USD
CY2020Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
17772000 USD
CY2020Q3 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2237424000 USD
CY2020Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2255196000 USD
CY2019Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
538000 USD
CY2019Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1943365000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1943903000 USD
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
6351000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
4309000 USD
CY2020Q3 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
6718000 USD
CY2019Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
1441000 USD
CY2020Q3 wtba Deferredtaxassetsleaseliabilities
Deferredtaxassetsleaseliabilities
2011000 USD
CY2019Q4 wtba Deferredtaxassetsleaseliabilities
Deferredtaxassetsleaseliabilities
2275000 USD
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
238000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
297000 USD
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
608000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
832000 USD
CY2020Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1178000 USD
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1114000 USD
CY2020Q3 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
0 USD
CY2019Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
3000 USD
CY2020Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
36000 USD
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
53000 USD
CY2020Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
17140000 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10324000 USD
CY2020Q3 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1955000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
2218000 USD
CY2020Q3 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
264000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
218000 USD
CY2020Q3 wtba Deferred Tax Liabilities Unrealized Gainson Availablefor Sale Securities
DeferredTaxLiabilitiesUnrealizedGainsonAvailableforSaleSecurities
1874000 USD
CY2019Q4 wtba Deferred Tax Liabilities Unrealized Gainson Availablefor Sale Securities
DeferredTaxLiabilitiesUnrealizedGainsonAvailableforSaleSecurities
352000 USD
CY2020Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
801000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
839000 USD
CY2020Q3 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
259000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
219000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5153000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3846000 USD
CY2020Q3 wtba Deferred Tax Assets Net Before Valuation Allowance
DeferredTaxAssetsNetBeforeValuationAllowance
11987000 USD
CY2019Q4 wtba Deferred Tax Assets Net Before Valuation Allowance
DeferredTaxAssetsNetBeforeValuationAllowance
6478000 USD
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1178000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1117000 USD
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
10809000 USD
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
5361000 USD
CY2020Q3 us-gaap Unused Commitments To Extend Credit
UnusedCommitmentsToExtendCredit
852983000 USD
CY2019Q4 us-gaap Unused Commitments To Extend Credit
UnusedCommitmentsToExtendCredit
680146000 USD
CY2020Q3 wtba Fhlbmpf Program Remaining Outstanding Balanceof Loans Sold
FHLBMPFProgramRemainingOutstandingBalanceofLoansSold
48417000 USD
CY2019Q4 wtba Fhlbmpf Program Remaining Outstanding Balanceof Loans Sold
FHLBMPFProgramRemainingOutstandingBalanceofLoansSold
63409000 USD
CY2020Q3 wtba Commitmentstoinvestinqualifiedaffordablehousingprojects
Commitmentstoinvestinqualifiedaffordablehousingprojects
3505000 USD
CY2019Q4 wtba Commitmentstoinvestinqualifiedaffordablehousingprojects
Commitmentstoinvestinqualifiedaffordablehousingprojects
2042000 USD
wtba Transfers Between Levels Fair Value Disclosure
TransfersBetweenLevelsFairValueDisclosure
0 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10. Risks and Uncertainties</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 as a global pandemic, which continues to spread throughout the United States and around the world. The COVID-19 pandemic has adversely affected, and continues to adversely affect, economic activity globally, nationally and locally. Actions taken around the world to help mitigate the spread of COVID-19 include restrictions on travel, quarantines in certain areas, and forced closures for certain types of public places, businesses and schools. COVID-19 and actions taken to mitigate the spread of it have had and are expected to continue to have an adverse impact on the economies and financial markets of many countries, including the geographical area in which the Company operates. Due to the COVID-19 pandemic, market interest rates have declined significantly, with the 10-year Treasury bond falling below 1.00 percent on March 3, 2020 for the first time. Such events have adversely affected business and consumer confidence, generally, and the Company and its customers, and their respective suppliers, vendors and processors, have been adversely affected. On March 3, 2020, the Federal Open Market Committee reduced the targeted federal funds interest rate range by 50 basis points to 1.00 - 1.25 percent. This range was further reduced to 0.0 - 0.25 percent on March 16, 2020. On March 27, 2020, the CARES Act was enacted to, among other provisions, provide emergency assistance for individuals, families and businesses affected by the COVID-19 pandemic. These reductions in interest rates and other effects of the COVID-19 pandemic may adversely affect the Company's financial condition and results of operations in future periods. The extent of the pandemic's effect on our business will depend on many factors, primarily including the speed and extent of any recovery from the related economic recession. Among other things, this will depend on the duration of the COVID-19 pandemic, particularly in our Iowa and Minnesota markets, the development and distribution of vaccines, therapies and other public health initiatives to control the spread of the disease, the nature and size of federal economic stimulus and other governmental efforts, and the possibility of additional state lockdown or stay-at-home orders in our markets. It is reasonably possible that estimates made in the financial statements could be materially and adversely impacted in the near term as a result of these conditions, including expected credit losses on loans.</span></div>
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
7526000 USD
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2020Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4000000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.28

Files In Submission

Name View Source Status
0001166928-20-000125-index-headers.html Edgar Link pending
0001166928-20-000125-index.html Edgar Link pending
0001166928-20-000125.txt Edgar Link pending
0001166928-20-000125-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wtba-20200930.htm Edgar Link pending
wtba-20200930.xsd Edgar Link pending
wtba-20200930xex311.htm Edgar Link pending
wtba-20200930xex312.htm Edgar Link pending
wtba-20200930xex321.htm Edgar Link pending
wtba-20200930xex322.htm Edgar Link pending
wtba-20200930_cal.xml Edgar Link unprocessable
wtba-20200930_def.xml Edgar Link unprocessable
wtba-20200930_htm.xml Edgar Link completed
wtba-20200930_lab.xml Edgar Link unprocessable
wtba-20200930_pre.xml Edgar Link unprocessable